Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Src family tyrosine kinases regulate oocyte maturation and fertilization in many species, yet their physiological roles in Xenopus laevis (X. laevis) remain incompletely defined. Here, we generated three X. laevis Src (xSrc) constructs with defined point mutations allowing for selective immunochemical detection and controlled modulation of kinase activity: wild type (xSrcWT, Arg121His), constitutively active (xSrcKA, Arg121His/Tyr526Phe), and kinase-negative (xSrcKN, Arg121His/Lys294Met). Capped mRNAs were microinjected into immature oocytes, and effects on meiotic maturation and egg activation were analyzed. All constructs produced detectable Src protein within 4-5 h after injection without inducing progesterone-independent maturation. Following progesterone treatment, MAP kinase phosphorylation, CDK1 activation, and germinal vesicle breakdown (GVBD) occurred normally in all groups, although xSrcKA-expressing oocytes showed a modest but reproducible acceleration of MAPK activation and GVBD. Global tyrosine phosphorylation analysis revealed increased phosphorylation of several proteins, including a prominent ~50 kDa substrate, specifically in xSrcKA oocytes. After maturation, oocytes were subjected to artificial activation. xSrcKN-expressing oocytes responded normally to Ca2+ ionophore (A23187), indicating that Src activity is not required for direct Ca2+-mediated activation. In contrast, xSrcKN oocytes exhibited markedly reduced activation in response to hydrogen peroxide or Cathepsin B, which stimulate membrane-associated signaling pathways. These findings demonstrate that Src kinase activity is required for membrane signal-mediated egg activation but is dispensable for activation driven by direct intracellular Ca2+ elevation. Collectively, our results identify Src kinase as a positive regulator of progesterone-induced meiotic maturation and a critical mediator of specific fertilization-like activation pathways in X. laevis.
Figure 1. Schematic representation of wild-type and mutant X. laevis Src (xSrc) constructs used for expression in oocytes. The full-length xSrc2 protein (accession no. NP_001080738.1) contains three conserved domains: SH3, SH2, and SH1 (kinase domain), with critical regulatory residues Lys294 (ATP-binding site), Tyr415 (autophosphorylation site), and Tyr526 (C-terminal inhibitory phosphorylation site). Three expression constructs were generated: wild type (xSrcWT), constitutively active (xSrcKA, Tyr526Phe), and kinase-negative (xSrcKN, Lys294Met). To enable immunochemical detection distinct from endogenous Src proteins, all constructs included a common Arg121His substitution within the SH3 domain, which renders the recombinant proteins specifically recognizable by the monoclonal antibody mAb327 (anti-human/mouse/chicken Src).
Figure 2. Time-dependent expression of recombinant xSrc proteins in X. laevis oocytes following mRNA microinjection, and progesterone-induced MAPK activation, CDK1/Cdc2 dephosphorylation, and GVBD occur normally in oocytes expressing recombinant xSrc proteins. (A) Left panels: Recombinant xSrc proteins, as indicated by asterisks (*), were detected by immunoprecipitation (IP) using mAb327 followed by immunoblotting (IB). All constructs became detectable approximately 4–5 h after mRNA injection. Middle panels: Total Src protein levels were examined using an antibody that recognizes both endogenous (**) and recombinant xSrc (*). Recombinant xSrc proteins were expressed at levels comparable to or higher than endogenous Src. Right panels: Representative bright-field images of oocytes at 0 h and 5 h after mRNA injection. No changes in surface pigmentation or germinal vesicle morphology were observed, indicating that forced expression of xSrc constructs did not induce premature maturation or morphological abnormalities. (B) Left panels: Immunoblotting for phosphorylated MAP kinase (pMAPK), as indicated by asterisks (*), showing time-dependent activation following exposure to 2 µM progesterone. Middle panels: Immunoblotting for CDK1/Cdc2 phosphorylated on the inhibitory tyrosine residue (pTyr-Cdc2), as indicated by asterisks (*). Dephosphorylation indicates activation of CDK1 and progression toward GVBD. Right panels: Representative images of oocytes at 0 h and 8 h after progesterone treatment. GVBD, visualized as disappearance of the germinal vesicle (arrowheads), occurred in all groups—including xSrcWT-, xSrcKA-, and xSrcKN-expressing oocytes—with kinetics similar to those of control oocytes. Together, these results indicate that forced expression of recombinant xSrc proteins, regardless of kinase activity, does not interfere with the hormonal maturation program of immature oocytes.
Figure 3. Acceleration of progesterone-induced GVBD and increased tyrosine phosphorylation in oocytes expressing constitutively active xSrc. (A) Time course of GVBD in control oocytes and those expressing xSrcWT, xSrcKA, or xSrcKN. Oocytes expressing the constitutively active mutant xSrcKA displayed a modest but reproducible acceleration in GVBD onset compared with other groups. The percentage of GVBD was assessed at 1 h intervals following progesterone treatment. (B) Anti-phosphotyrosine immunoblot showing progesterone-induced tyrosine phosphorylation of multiple proteins. Oocytes expressing xSrcKA exhibited increased phosphorylation of several proteins relative to controls and other Src constructs. A strongly phosphorylated ∼50 kDa protein (**), distinct from recombinant xSrc itself (∼60 kDa; *) and MAPK (∼42 kDa; ***), was specifically enhanced in xSrcKA-expressing oocytes. This suggests the presence of an unidentified substrate whose phosphorylation is stimulated by elevated Src kinase activity.
Figure 4. Differential requirements for Src kinase activity during egg activation induced by A23187, H2O2, or Cathepsin B. Matured oocytes (mRNA injection for 5 h + progesterone treatment for 8 h) were subjected to the indicated activation stimuli. (A) A23187-induced activation. Left: MAPK dephosphorylation assessed by anti-pMAPK immunoblotting. Right: Percentage of oocytes undergoing cortical contraction. All three xSrc-expressing groups activated efficiently, similar to controls, indicating that Src kinase activity is not required for Ca2+-ionophore-induced activation. (B) H2O2-induced activation. Left: MAPK dephosphorylation profiles. Right: Quantification of cortical contraction. xSrcKN-expressing oocytes showed markedly reduced activation compared to control, xSrcWT, and xSrcKA oocytes. (C) Cathepsin B-induced activation. Left: MAPK dephosphorylation following Cathepsin B treatment. Right: Activation rates based on cortical contraction. As with H2O2, xSrcKN-expressing oocytes displayed a strong reduction in responsiveness, demonstrating the requirement of Src kinase activity in membrane-associated activation signaling. In all panels, asterisks (*) indicate the positions of pMAPK.
